Finasteride Market Outlook:
Finasteride Market size was valued at approximately USD 1.6 billion in 2025 and is projected to reach around USD 4.6 billion by the end of 2035, rising at a CAGR of approximately 7.5% during the forecast period, i.e., between 2026-2035. In 2026, the industry size of finasteride is estimated at USD 1.7 billion in size.
The research and development in the market are mainly focused on increasing the efficacy and patient compliance with the help of innovative approaches. Prominent trends in the R&D incorporate the development of the advanced drug delivery system that renders sustained therapeutic effects. Moreover, researchers are scrutinizing various mechanisms of action that include protein degraders focused on hair loss. These efforts emphasize the development of a customized medicine strategy to provide tailored treatment on the basis of the individual genetic profiles.
On the production side, finasteride's active pharmaceutical ingredient is manufactured in India and China, while final product assembly and quality checking are executed in the U.S. and Europe under GMP-environmental conditions. The cost and supply of finasteride are generally affected by overall production costs and economic factors. Companies are taking various measures to maintain the supply chain dynamics for sustained growth. Some of the prominent steps are diversification of the supply chain and expanding the production capacity. Also, companies are focusing on exploring personalized medicine approaches to garner the attention of a large patient base.
